Shira N. Dinner, MD- Inotuzumab, Ozogamicin, and Blinatumomab

Shira N. Dinner, MD.  Associate Professor, Medicine, Hematology Oncology Division; Feinberg School of Medicine Sherra Diner, MD, an esteemed associate professor and leukemia physician at Northwestern University in Chicago, delves into a compelling discussion regarding the treatment of elderly adults with ALS. She emphasizes a departure from conventional chemotherapy approaches, advocating for the adoption of … Continue reading Shira N. Dinner, MD- Inotuzumab, Ozogamicin, and Blinatumomab